Seems like a study that might give doctors favoring fish oil supplements even more ammunition to support their bad choices since the study used a product, "crafted by CNC GELCAPS CORPORATION—an entity accredited with ISO 22000, HACCP, and GMP standards—(which) incorporates an orange flavoring agent to conceal the taste of EPA."
Thanks for the post. Here's a recap + ClinicalTrials.gov website: $AMRN More info on the Taiwan RCT to reduce migraine frequency & severity with high dose EPA (EPADEL): Here is the Peer Reviewed Publication:
The primary outcome was the decrease in migraine attacks over a 12-week period & the severity. Several Secondary Outcomes are listed in the publication. It appears that many Outcome measures were met with significance including the Primary: Comparing baseline values to those at week 12, the EPA group displayed significant improvements in various parameters within the group, including a marked reduction in monthly migraine frequency (7.4 ± 5.0 days vs. 3.0 ± 2.0 days, p < 0.0001), decreased usage of acute headache medication (2.9 ± 3.2 days vs. 1.6 ± 1.7 days, p = 0.013), lowered headache severity (VAS score: 5.5 ± 2.0 vs. 4.2 ± 2.6, p = 0.004),